BML Capital Management as of Dec. 31, 2022
Portfolio Holdings for BML Capital Management
BML Capital Management holds 25 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abercrombie & Fitch Cl A (ANF) | 12.5 | $13M | 571k | 22.91 | |
| Imara | 11.8 | $12M | 3.0M | 4.09 | |
| Tillys Cl A (TLYS) | 10.0 | $11M | 1.2M | 9.05 | |
| Disc Medicine (IRON) | 9.5 | $9.9M | 500k | 19.89 | |
| Spdr Ser Tr Bloomberg 1-3 Mo (BIL) | 8.7 | $9.1M | 100k | 91.47 | |
| Pardes Biosciences | 7.9 | $8.2M | 4.9M | 1.69 | |
| Eliem Therapeutics (CLYM) | 6.4 | $6.7M | 1.8M | 3.67 | |
| Satsuma Pharmaceuticals Ord | 5.5 | $5.8M | 6.4M | 0.90 | |
| Sesen Bio | 4.8 | $5.0M | 8.2M | 0.61 | |
| Adverum Biotechnologies | 3.9 | $4.1M | 7.1M | 0.58 | |
| Verrica Pharmaceuticals (VRCA) | 2.9 | $3.1M | 1.1M | 2.75 | |
| Metacrine Ord | 2.6 | $2.8M | 6.2M | 0.45 | |
| Athira Pharma (ATHA) | 2.2 | $2.3M | 715k | 3.17 | |
| Astrotech Corp (ASTC) | 2.1 | $2.2M | 220k | 9.99 | |
| Arca Biopharma (ABIO) | 1.9 | $2.0M | 858k | 2.37 | |
| Richardson Electronics (RELL) | 1.9 | $2.0M | 95k | 21.33 | |
| Forte Biosciences | 1.4 | $1.5M | 1.5M | 1.00 | |
| Retractable Technologies (RVP) | 1.0 | $1.1M | 669k | 1.64 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $713k | 180k | 3.96 | |
| Graybug Vision Common | 0.6 | $618k | 1.2M | 0.50 | |
| Lisata Therapeutics (LSTA) | 0.6 | $617k | 244k | 2.53 | |
| Passage Bio (PASG) | 0.4 | $466k | 338k | 1.38 | |
| Adicet Bio (ACET) | 0.3 | $268k | 30k | 8.94 | |
| Spruce Biosciences (SPRB) | 0.2 | $243k | 222k | 1.10 | |
| Elevation Oncology (ELEV) | 0.0 | $38k | 40k | 0.95 |
